Biocon on 31 August announced that their wholly-owned subsidiary, Biocon Pharma Ltd received US Food and Drug Administration (USFDA) for its Abbreviated New Drug Application...
Biocon shares were trading 1% higher on 15 November after Biocon Biologics, a subsidiary of the company, announced receiving marketing authorisation from the Medicines and...
Shares of Biocon tumbled 4% on 18 October after the company’s Malaysia unit was red-flagged by the USFDA (US Food and Drug Administration). The company...
The biopharmaceutical company Biocon has released its financial results for the April-June quarter for the 2023-24 fiscal year. The company reported a 30% YoY decline...
Biocon shares fell 2% to Rs 258.50 at 9:27 am on Monday after the company acknowledged six US Food and Drug Administration (USFDA) observations. The...
On June 5, Biocon shares opened positively, gaining 1.5% as USFDA dispensed no observations on the company’s Bengaluru facility. Biotechnology company Biocon has logged that...
Shares of Biocon rose nearly 8% in early trading on May 24, boosted by the drugmaker’s strong fourth-quarter earnings. The drugmaker on Tuesday posted a...